These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 12000494

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety.
    Müller U, Helbling A, Berchtold E.
    J Allergy Clin Immunol; 1992 Feb; 89(2):529-35. PubMed ID: 1740583
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy.
    Hockenhull J, Elremeli M, Cherry MG, Mahon J, Lai M, Darroch J, Oyee J, Boland A, Dickson R, Dundar Y, Boyle R.
    Health Technol Assess; 2012 Feb; 16(12):III-IV, 1-110. PubMed ID: 22409877
    [Abstract] [Full Text] [Related]

  • 25. Duration of venom immunotherapy: relationship to the severity of symptoms of initial insect sting anaphylaxis.
    Reisman RE.
    J Allergy Clin Immunol; 1993 Dec; 92(6):831-6. PubMed ID: 8258617
    [Abstract] [Full Text] [Related]

  • 26. Bee venom allergy in beekeepers and their family members.
    Müller UR.
    Curr Opin Allergy Clin Immunol; 2005 Aug; 5(4):343-7. PubMed ID: 15985817
    [Abstract] [Full Text] [Related]

  • 27. Case report of venom immunotherapy for a patient with large local reactions.
    Hamilton RG, Golden DB, Kagey-Sobotka A, Lichtenstein LM.
    Ann Allergy Asthma Immunol; 2001 Aug; 87(2):134-7. PubMed ID: 11527245
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Subcutaneous venom immunotherapy in children: Efficacy and safety.
    Gür Çetinkaya P, Esenboğa S, Uysal Soyer Ö, Tuncer A, Şekerel BE, Şahiner ÜM.
    Ann Allergy Asthma Immunol; 2018 Apr; 120(4):424-428. PubMed ID: 29625665
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom.
    Stritzke AI, Eng PA.
    Clin Exp Allergy; 2013 Aug; 43(8):950-5. PubMed ID: 23889248
    [Abstract] [Full Text] [Related]

  • 33. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy.
    Haeberli G, Brönnimann M, Hunziker T, Müller U.
    Clin Exp Allergy; 2003 Sep; 33(9):1216-20. PubMed ID: 12956741
    [Abstract] [Full Text] [Related]

  • 34. Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy.
    von Moos S, Graf N, Johansen P, Müllner G, Kündig TM, Senti G.
    Int Arch Allergy Immunol; 2013 Sep; 160(1):86-92. PubMed ID: 22948338
    [Abstract] [Full Text] [Related]

  • 35. The value of an in-hospital insect sting challenge as a criterion for application or omission of venom immunotherapy.
    Blaauw PJ, Smithuis OL, Elbers AR.
    J Allergy Clin Immunol; 1996 Jul; 98(1):39-47. PubMed ID: 8765816
    [Abstract] [Full Text] [Related]

  • 36. Anaphylactic reactions to bee-sting challenges in allergic children are not modified by endogenous catecholamines.
    Hauk P, Otto J, Schwab KO, Kaufmehl K, Urbanek R, Eichler HG, Forster J.
    Pediatr Res; 1995 Dec; 38(6):998-1002. PubMed ID: 8618807
    [Abstract] [Full Text] [Related]

  • 37. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
    Spoerl D, Bircher AJ, Scherer K.
    J Investig Allergol Clin Immunol; 2011 Dec; 21(1):22-7. PubMed ID: 21370719
    [Abstract] [Full Text] [Related]

  • 38. Safety and Efficacy of a Progressively Prolonged Maintenance Interval of Venom Immunotherapy.
    Kontou-Fili K, Pitsios C, Kompoti E, Giannakopoulos D, Kouridakis S.
    Int Arch Allergy Immunol; 2018 Dec; 176(1):39-43. PubMed ID: 29649812
    [Abstract] [Full Text] [Related]

  • 39. [Wasp and bee venom allergy].
    Knulst AC, de Maat-Bleeker F, Bruijnzeel-Koomen CA.
    Ned Tijdschr Geneeskd; 1998 Apr 18; 142(16):889-92. PubMed ID: 9623183
    [Abstract] [Full Text] [Related]

  • 40. Bee venom anti-idiotypic antibody is associated with protection in beekeepers and bee sting-sensitive patients receiving immunotherapy against allergic reactions.
    Khan RH, Szewczuk MR, Day JH.
    J Allergy Clin Immunol; 1991 Aug 18; 88(2):199-208. PubMed ID: 1880320
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.